CLINICAL_TRIALS
trial_result
· 2010-03-19
Clinical Trial Update: Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia [Phase 1]
Summary
Phase 1 multiple-dose safety study of PF-04802540 in subjects with schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED